Global Pharmaceutical CDMO Services Market Growth (Status and Outlook) 2025-2031
According to this study, the global Pharmaceutical CDMO Services market size will reach US$ million by 2031.
A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Pharmaceutical CDMO Services Industry Forecast” looks at past sales and reviews total world Pharmaceutical CDMO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical CDMO Services sales for 2025 through 2031. With Pharmaceutical CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Pharmaceutical CDMO Services Industry Forecast” looks at past sales and reviews total world Pharmaceutical CDMO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical CDMO Services sales for 2025 through 2031. With Pharmaceutical CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Drug Substance Development and Manufacturing
- Specialized Services
- Lab-based Services
- Innovative Medicine
- Patented Drug
- Patent Expired Drug
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Recipharm AB
- AMRI Global
- Patheon N.V.
- Aenova Group
- Catalent, Inc.
- Amatsigroup
- WuXi AppTec Group
- Strides Pharma Science Limited
- Piramal Pharma Solutions
- Siegfried Ltd
- Fareva Group
- FAMAR Health Care Services
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CDMO Services Market Size (2020-2031)
2.1.2 Pharmaceutical CDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmaceutical CDMO Services by Country/Region (2020, 2024 & 2031)
2.2 Pharmaceutical CDMO Services Segment by Type
2.2.1 Drug Substance Development and Manufacturing
2.2.2 Specialized Services
2.2.3 Lab-based Services
2.3 Pharmaceutical CDMO Services Market Size by Type
2.3.1 Pharmaceutical CDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
2.4 Pharmaceutical CDMO Services Segment by Application
2.4.1 Innovative Medicine
2.4.2 Patented Drug
2.4.3 Patent Expired Drug
2.5 Pharmaceutical CDMO Services Market Size by Application
2.5.1 Pharmaceutical CDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
3 PHARMACEUTICAL CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Pharmaceutical CDMO Services Market Size Market Share by Player
3.1.1 Global Pharmaceutical CDMO Services Revenue by Player (2020-2025)
3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Player (2020-2025)
3.2 Global Pharmaceutical CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CDMO SERVICES BY REGION
4.1 Pharmaceutical CDMO Services Market Size by Region (2020-2025)
4.2 Global Pharmaceutical CDMO Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical CDMO Services Market Size Growth (2020-2025)
4.4 APAC Pharmaceutical CDMO Services Market Size Growth (2020-2025)
4.5 Europe Pharmaceutical CDMO Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Pharmaceutical CDMO Services Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Pharmaceutical CDMO Services Market Size by Country (2020-2025)
5.2 Americas Pharmaceutical CDMO Services Market Size by Type (2020-2025)
5.3 Americas Pharmaceutical CDMO Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CDMO Services Market Size by Region (2020-2025)
6.2 APAC Pharmaceutical CDMO Services Market Size by Type (2020-2025)
6.3 APAC Pharmaceutical CDMO Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CDMO Services Market Size by Country (2020-2025)
7.2 Europe Pharmaceutical CDMO Services Market Size by Type (2020-2025)
7.3 Europe Pharmaceutical CDMO Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CDMO Services by Region (2020-2025)
8.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CDMO SERVICES MARKET FORECAST
10.1 Global Pharmaceutical CDMO Services Forecast by Region (2026-2031)
10.1.1 Global Pharmaceutical CDMO Services Forecast by Region (2026-2031)
10.1.2 Americas Pharmaceutical CDMO Services Forecast
10.1.3 APAC Pharmaceutical CDMO Services Forecast
10.1.4 Europe Pharmaceutical CDMO Services Forecast
10.1.5 Middle East & Africa Pharmaceutical CDMO Services Forecast
10.2 Americas Pharmaceutical CDMO Services Forecast by Country (2026-2031)
10.2.1 United States Market Pharmaceutical CDMO Services Forecast
10.2.2 Canada Market Pharmaceutical CDMO Services Forecast
10.2.3 Mexico Market Pharmaceutical CDMO Services Forecast
10.2.4 Brazil Market Pharmaceutical CDMO Services Forecast
10.3 APAC Pharmaceutical CDMO Services Forecast by Region (2026-2031)
10.3.1 China Pharmaceutical CDMO Services Market Forecast
10.3.2 Japan Market Pharmaceutical CDMO Services Forecast
10.3.3 Korea Market Pharmaceutical CDMO Services Forecast
10.3.4 Southeast Asia Market Pharmaceutical CDMO Services Forecast
10.3.5 India Market Pharmaceutical CDMO Services Forecast
10.3.6 Australia Market Pharmaceutical CDMO Services Forecast
10.4 Europe Pharmaceutical CDMO Services Forecast by Country (2026-2031)
10.4.1 Germany Market Pharmaceutical CDMO Services Forecast
10.4.2 France Market Pharmaceutical CDMO Services Forecast
10.4.3 UK Market Pharmaceutical CDMO Services Forecast
10.4.4 Italy Market Pharmaceutical CDMO Services Forecast
10.4.5 Russia Market Pharmaceutical CDMO Services Forecast
10.5 Middle East & Africa Pharmaceutical CDMO Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Pharmaceutical CDMO Services Forecast
10.5.2 South Africa Market Pharmaceutical CDMO Services Forecast
10.5.3 Israel Market Pharmaceutical CDMO Services Forecast
10.5.4 Turkey Market Pharmaceutical CDMO Services Forecast
10.6 Global Pharmaceutical CDMO Services Forecast by Type (2026-2031)
10.7 Global Pharmaceutical CDMO Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Pharmaceutical CDMO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Recipharm AB
11.1.1 Recipharm AB Company Information
11.1.2 Recipharm AB Pharmaceutical CDMO Services Product Offered
11.1.3 Recipharm AB Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Recipharm AB Main Business Overview
11.1.5 Recipharm AB Latest Developments
11.2 AMRI Global
11.2.1 AMRI Global Company Information
11.2.2 AMRI Global Pharmaceutical CDMO Services Product Offered
11.2.3 AMRI Global Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AMRI Global Main Business Overview
11.2.5 AMRI Global Latest Developments
11.3 Patheon N.V.
11.3.1 Patheon N.V. Company Information
11.3.2 Patheon N.V. Pharmaceutical CDMO Services Product Offered
11.3.3 Patheon N.V. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Patheon N.V. Main Business Overview
11.3.5 Patheon N.V. Latest Developments
11.4 Aenova Group
11.4.1 Aenova Group Company Information
11.4.2 Aenova Group Pharmaceutical CDMO Services Product Offered
11.4.3 Aenova Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Aenova Group Main Business Overview
11.4.5 Aenova Group Latest Developments
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Information
11.5.2 Catalent, Inc. Pharmaceutical CDMO Services Product Offered
11.5.3 Catalent, Inc. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Catalent, Inc. Main Business Overview
11.5.5 Catalent, Inc. Latest Developments
11.6 Amatsigroup
11.6.1 Amatsigroup Company Information
11.6.2 Amatsigroup Pharmaceutical CDMO Services Product Offered
11.6.3 Amatsigroup Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Amatsigroup Main Business Overview
11.6.5 Amatsigroup Latest Developments
11.7 WuXi AppTec Group
11.7.1 WuXi AppTec Group Company Information
11.7.2 WuXi AppTec Group Pharmaceutical CDMO Services Product Offered
11.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 WuXi AppTec Group Main Business Overview
11.7.5 WuXi AppTec Group Latest Developments
11.8 Strides Pharma Science Limited
11.8.1 Strides Pharma Science Limited Company Information
11.8.2 Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offered
11.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Strides Pharma Science Limited Main Business Overview
11.8.5 Strides Pharma Science Limited Latest Developments
11.9 Piramal Pharma Solutions
11.9.1 Piramal Pharma Solutions Company Information
11.9.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offered
11.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Piramal Pharma Solutions Main Business Overview
11.9.5 Piramal Pharma Solutions Latest Developments
11.10 Siegfried Ltd
11.10.1 Siegfried Ltd Company Information
11.10.2 Siegfried Ltd Pharmaceutical CDMO Services Product Offered
11.10.3 Siegfried Ltd Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Siegfried Ltd Main Business Overview
11.10.5 Siegfried Ltd Latest Developments
11.11 Fareva Group
11.11.1 Fareva Group Company Information
11.11.2 Fareva Group Pharmaceutical CDMO Services Product Offered
11.11.3 Fareva Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Fareva Group Main Business Overview
11.11.5 Fareva Group Latest Developments
11.12 FAMAR Health Care Services
11.12.1 FAMAR Health Care Services Company Information
11.12.2 FAMAR Health Care Services Pharmaceutical CDMO Services Product Offered
11.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 FAMAR Health Care Services Main Business Overview
11.12.5 FAMAR Health Care Services Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CDMO Services Market Size (2020-2031)
2.1.2 Pharmaceutical CDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmaceutical CDMO Services by Country/Region (2020, 2024 & 2031)
2.2 Pharmaceutical CDMO Services Segment by Type
2.2.1 Drug Substance Development and Manufacturing
2.2.2 Specialized Services
2.2.3 Lab-based Services
2.3 Pharmaceutical CDMO Services Market Size by Type
2.3.1 Pharmaceutical CDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
2.4 Pharmaceutical CDMO Services Segment by Application
2.4.1 Innovative Medicine
2.4.2 Patented Drug
2.4.3 Patent Expired Drug
2.5 Pharmaceutical CDMO Services Market Size by Application
2.5.1 Pharmaceutical CDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
3 PHARMACEUTICAL CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Pharmaceutical CDMO Services Market Size Market Share by Player
3.1.1 Global Pharmaceutical CDMO Services Revenue by Player (2020-2025)
3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Player (2020-2025)
3.2 Global Pharmaceutical CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CDMO SERVICES BY REGION
4.1 Pharmaceutical CDMO Services Market Size by Region (2020-2025)
4.2 Global Pharmaceutical CDMO Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical CDMO Services Market Size Growth (2020-2025)
4.4 APAC Pharmaceutical CDMO Services Market Size Growth (2020-2025)
4.5 Europe Pharmaceutical CDMO Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Pharmaceutical CDMO Services Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Pharmaceutical CDMO Services Market Size by Country (2020-2025)
5.2 Americas Pharmaceutical CDMO Services Market Size by Type (2020-2025)
5.3 Americas Pharmaceutical CDMO Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CDMO Services Market Size by Region (2020-2025)
6.2 APAC Pharmaceutical CDMO Services Market Size by Type (2020-2025)
6.3 APAC Pharmaceutical CDMO Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CDMO Services Market Size by Country (2020-2025)
7.2 Europe Pharmaceutical CDMO Services Market Size by Type (2020-2025)
7.3 Europe Pharmaceutical CDMO Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CDMO Services by Region (2020-2025)
8.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CDMO SERVICES MARKET FORECAST
10.1 Global Pharmaceutical CDMO Services Forecast by Region (2026-2031)
10.1.1 Global Pharmaceutical CDMO Services Forecast by Region (2026-2031)
10.1.2 Americas Pharmaceutical CDMO Services Forecast
10.1.3 APAC Pharmaceutical CDMO Services Forecast
10.1.4 Europe Pharmaceutical CDMO Services Forecast
10.1.5 Middle East & Africa Pharmaceutical CDMO Services Forecast
10.2 Americas Pharmaceutical CDMO Services Forecast by Country (2026-2031)
10.2.1 United States Market Pharmaceutical CDMO Services Forecast
10.2.2 Canada Market Pharmaceutical CDMO Services Forecast
10.2.3 Mexico Market Pharmaceutical CDMO Services Forecast
10.2.4 Brazil Market Pharmaceutical CDMO Services Forecast
10.3 APAC Pharmaceutical CDMO Services Forecast by Region (2026-2031)
10.3.1 China Pharmaceutical CDMO Services Market Forecast
10.3.2 Japan Market Pharmaceutical CDMO Services Forecast
10.3.3 Korea Market Pharmaceutical CDMO Services Forecast
10.3.4 Southeast Asia Market Pharmaceutical CDMO Services Forecast
10.3.5 India Market Pharmaceutical CDMO Services Forecast
10.3.6 Australia Market Pharmaceutical CDMO Services Forecast
10.4 Europe Pharmaceutical CDMO Services Forecast by Country (2026-2031)
10.4.1 Germany Market Pharmaceutical CDMO Services Forecast
10.4.2 France Market Pharmaceutical CDMO Services Forecast
10.4.3 UK Market Pharmaceutical CDMO Services Forecast
10.4.4 Italy Market Pharmaceutical CDMO Services Forecast
10.4.5 Russia Market Pharmaceutical CDMO Services Forecast
10.5 Middle East & Africa Pharmaceutical CDMO Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Pharmaceutical CDMO Services Forecast
10.5.2 South Africa Market Pharmaceutical CDMO Services Forecast
10.5.3 Israel Market Pharmaceutical CDMO Services Forecast
10.5.4 Turkey Market Pharmaceutical CDMO Services Forecast
10.6 Global Pharmaceutical CDMO Services Forecast by Type (2026-2031)
10.7 Global Pharmaceutical CDMO Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Pharmaceutical CDMO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Recipharm AB
11.1.1 Recipharm AB Company Information
11.1.2 Recipharm AB Pharmaceutical CDMO Services Product Offered
11.1.3 Recipharm AB Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Recipharm AB Main Business Overview
11.1.5 Recipharm AB Latest Developments
11.2 AMRI Global
11.2.1 AMRI Global Company Information
11.2.2 AMRI Global Pharmaceutical CDMO Services Product Offered
11.2.3 AMRI Global Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AMRI Global Main Business Overview
11.2.5 AMRI Global Latest Developments
11.3 Patheon N.V.
11.3.1 Patheon N.V. Company Information
11.3.2 Patheon N.V. Pharmaceutical CDMO Services Product Offered
11.3.3 Patheon N.V. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Patheon N.V. Main Business Overview
11.3.5 Patheon N.V. Latest Developments
11.4 Aenova Group
11.4.1 Aenova Group Company Information
11.4.2 Aenova Group Pharmaceutical CDMO Services Product Offered
11.4.3 Aenova Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Aenova Group Main Business Overview
11.4.5 Aenova Group Latest Developments
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Information
11.5.2 Catalent, Inc. Pharmaceutical CDMO Services Product Offered
11.5.3 Catalent, Inc. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Catalent, Inc. Main Business Overview
11.5.5 Catalent, Inc. Latest Developments
11.6 Amatsigroup
11.6.1 Amatsigroup Company Information
11.6.2 Amatsigroup Pharmaceutical CDMO Services Product Offered
11.6.3 Amatsigroup Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Amatsigroup Main Business Overview
11.6.5 Amatsigroup Latest Developments
11.7 WuXi AppTec Group
11.7.1 WuXi AppTec Group Company Information
11.7.2 WuXi AppTec Group Pharmaceutical CDMO Services Product Offered
11.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 WuXi AppTec Group Main Business Overview
11.7.5 WuXi AppTec Group Latest Developments
11.8 Strides Pharma Science Limited
11.8.1 Strides Pharma Science Limited Company Information
11.8.2 Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offered
11.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Strides Pharma Science Limited Main Business Overview
11.8.5 Strides Pharma Science Limited Latest Developments
11.9 Piramal Pharma Solutions
11.9.1 Piramal Pharma Solutions Company Information
11.9.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offered
11.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Piramal Pharma Solutions Main Business Overview
11.9.5 Piramal Pharma Solutions Latest Developments
11.10 Siegfried Ltd
11.10.1 Siegfried Ltd Company Information
11.10.2 Siegfried Ltd Pharmaceutical CDMO Services Product Offered
11.10.3 Siegfried Ltd Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Siegfried Ltd Main Business Overview
11.10.5 Siegfried Ltd Latest Developments
11.11 Fareva Group
11.11.1 Fareva Group Company Information
11.11.2 Fareva Group Pharmaceutical CDMO Services Product Offered
11.11.3 Fareva Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Fareva Group Main Business Overview
11.11.5 Fareva Group Latest Developments
11.12 FAMAR Health Care Services
11.12.1 FAMAR Health Care Services Company Information
11.12.2 FAMAR Health Care Services Pharmaceutical CDMO Services Product Offered
11.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 FAMAR Health Care Services Main Business Overview
11.12.5 FAMAR Health Care Services Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical CDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Pharmaceutical CDMO Services Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Drug Substance Development and Manufacturing
Table 4. Major Players of Specialized Services
Table 5. Major Players of Lab-based Services
Table 6. Pharmaceutical CDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Pharmaceutical CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
Table 9. Pharmaceutical CDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Pharmaceutical CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
Table 12. Global Pharmaceutical CDMO Services Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Pharmaceutical CDMO Services Revenue Market Share by Player (2020-2025)
Table 14. Pharmaceutical CDMO Services Key Players Head office and Products Offered
Table 15. Pharmaceutical CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmaceutical CDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Pharmaceutical CDMO Services Market Size Market Share by Region (2020-2025)
Table 20. Global Pharmaceutical CDMO Services Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Pharmaceutical CDMO Services Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Pharmaceutical CDMO Services Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Pharmaceutical CDMO Services Market Size Market Share by Country (2020-2025)
Table 24. Americas Pharmaceutical CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
Table 26. Americas Pharmaceutical CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
Table 28. APAC Pharmaceutical CDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Pharmaceutical CDMO Services Market Size Market Share by Region (2020-2025)
Table 30. APAC Pharmaceutical CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Pharmaceutical CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Pharmaceutical CDMO Services Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Pharmaceutical CDMO Services Market Size Market Share by Country (2020-2025)
Table 34. Europe Pharmaceutical CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Pharmaceutical CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Pharmaceutical CDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO Services
Table 40. Key Market Challenges & Risks of Pharmaceutical CDMO Services
Table 41. Key Industry Trends of Pharmaceutical CDMO Services
Table 42. Global Pharmaceutical CDMO Services Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Pharmaceutical CDMO Services Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Pharmaceutical CDMO Services Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Recipharm AB Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 47. Recipharm AB Pharmaceutical CDMO Services Product Offered
Table 48. Recipharm AB Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Recipharm AB Main Business
Table 50. Recipharm AB Latest Developments
Table 51. AMRI Global Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 52. AMRI Global Pharmaceutical CDMO Services Product Offered
Table 53. AMRI Global Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. AMRI Global Main Business
Table 55. AMRI Global Latest Developments
Table 56. Patheon N.V. Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 57. Patheon N.V. Pharmaceutical CDMO Services Product Offered
Table 58. Patheon N.V. Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Patheon N.V. Main Business
Table 60. Patheon N.V. Latest Developments
Table 61. Aenova Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 62. Aenova Group Pharmaceutical CDMO Services Product Offered
Table 63. Aenova Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Aenova Group Main Business
Table 65. Aenova Group Latest Developments
Table 66. Catalent, Inc. Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 67. Catalent, Inc. Pharmaceutical CDMO Services Product Offered
Table 68. Catalent, Inc. Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Catalent, Inc. Main Business
Table 70. Catalent, Inc. Latest Developments
Table 71. Amatsigroup Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 72. Amatsigroup Pharmaceutical CDMO Services Product Offered
Table 73. Amatsigroup Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Amatsigroup Main Business
Table 75. Amatsigroup Latest Developments
Table 76. WuXi AppTec Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 77. WuXi AppTec Group Pharmaceutical CDMO Services Product Offered
Table 78. WuXi AppTec Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. WuXi AppTec Group Main Business
Table 80. WuXi AppTec Group Latest Developments
Table 81. Strides Pharma Science Limited Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 82. Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offered
Table 83. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Strides Pharma Science Limited Main Business
Table 85. Strides Pharma Science Limited Latest Developments
Table 86. Piramal Pharma Solutions Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 87. Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offered
Table 88. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Piramal Pharma Solutions Main Business
Table 90. Piramal Pharma Solutions Latest Developments
Table 91. Siegfried Ltd Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 92. Siegfried Ltd Pharmaceutical CDMO Services Product Offered
Table 93. Siegfried Ltd Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Siegfried Ltd Main Business
Table 95. Siegfried Ltd Latest Developments
Table 96. Fareva Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 97. Fareva Group Pharmaceutical CDMO Services Product Offered
Table 98. Fareva Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Fareva Group Main Business
Table 100. Fareva Group Latest Developments
Table 101. FAMAR Health Care Services Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 102. FAMAR Health Care Services Pharmaceutical CDMO Services Product Offered
Table 103. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. FAMAR Health Care Services Main Business
Table 105. FAMAR Health Care Services Latest Developments
Table 1. Pharmaceutical CDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Pharmaceutical CDMO Services Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Drug Substance Development and Manufacturing
Table 4. Major Players of Specialized Services
Table 5. Major Players of Lab-based Services
Table 6. Pharmaceutical CDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Pharmaceutical CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
Table 9. Pharmaceutical CDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Pharmaceutical CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
Table 12. Global Pharmaceutical CDMO Services Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Pharmaceutical CDMO Services Revenue Market Share by Player (2020-2025)
Table 14. Pharmaceutical CDMO Services Key Players Head office and Products Offered
Table 15. Pharmaceutical CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmaceutical CDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Pharmaceutical CDMO Services Market Size Market Share by Region (2020-2025)
Table 20. Global Pharmaceutical CDMO Services Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Pharmaceutical CDMO Services Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Pharmaceutical CDMO Services Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Pharmaceutical CDMO Services Market Size Market Share by Country (2020-2025)
Table 24. Americas Pharmaceutical CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
Table 26. Americas Pharmaceutical CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
Table 28. APAC Pharmaceutical CDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Pharmaceutical CDMO Services Market Size Market Share by Region (2020-2025)
Table 30. APAC Pharmaceutical CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Pharmaceutical CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Pharmaceutical CDMO Services Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Pharmaceutical CDMO Services Market Size Market Share by Country (2020-2025)
Table 34. Europe Pharmaceutical CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Pharmaceutical CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Pharmaceutical CDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO Services
Table 40. Key Market Challenges & Risks of Pharmaceutical CDMO Services
Table 41. Key Industry Trends of Pharmaceutical CDMO Services
Table 42. Global Pharmaceutical CDMO Services Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Pharmaceutical CDMO Services Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Pharmaceutical CDMO Services Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Recipharm AB Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 47. Recipharm AB Pharmaceutical CDMO Services Product Offered
Table 48. Recipharm AB Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Recipharm AB Main Business
Table 50. Recipharm AB Latest Developments
Table 51. AMRI Global Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 52. AMRI Global Pharmaceutical CDMO Services Product Offered
Table 53. AMRI Global Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. AMRI Global Main Business
Table 55. AMRI Global Latest Developments
Table 56. Patheon N.V. Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 57. Patheon N.V. Pharmaceutical CDMO Services Product Offered
Table 58. Patheon N.V. Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Patheon N.V. Main Business
Table 60. Patheon N.V. Latest Developments
Table 61. Aenova Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 62. Aenova Group Pharmaceutical CDMO Services Product Offered
Table 63. Aenova Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Aenova Group Main Business
Table 65. Aenova Group Latest Developments
Table 66. Catalent, Inc. Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 67. Catalent, Inc. Pharmaceutical CDMO Services Product Offered
Table 68. Catalent, Inc. Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Catalent, Inc. Main Business
Table 70. Catalent, Inc. Latest Developments
Table 71. Amatsigroup Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 72. Amatsigroup Pharmaceutical CDMO Services Product Offered
Table 73. Amatsigroup Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Amatsigroup Main Business
Table 75. Amatsigroup Latest Developments
Table 76. WuXi AppTec Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 77. WuXi AppTec Group Pharmaceutical CDMO Services Product Offered
Table 78. WuXi AppTec Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. WuXi AppTec Group Main Business
Table 80. WuXi AppTec Group Latest Developments
Table 81. Strides Pharma Science Limited Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 82. Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offered
Table 83. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Strides Pharma Science Limited Main Business
Table 85. Strides Pharma Science Limited Latest Developments
Table 86. Piramal Pharma Solutions Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 87. Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offered
Table 88. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Piramal Pharma Solutions Main Business
Table 90. Piramal Pharma Solutions Latest Developments
Table 91. Siegfried Ltd Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 92. Siegfried Ltd Pharmaceutical CDMO Services Product Offered
Table 93. Siegfried Ltd Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Siegfried Ltd Main Business
Table 95. Siegfried Ltd Latest Developments
Table 96. Fareva Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 97. Fareva Group Pharmaceutical CDMO Services Product Offered
Table 98. Fareva Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Fareva Group Main Business
Table 100. Fareva Group Latest Developments
Table 101. FAMAR Health Care Services Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 102. FAMAR Health Care Services Pharmaceutical CDMO Services Product Offered
Table 103. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. FAMAR Health Care Services Main Business
Table 105. FAMAR Health Care Services Latest Developments
LIST OF FIGURES
Figure 1. Pharmaceutical CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CDMO Services Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Pharmaceutical CDMO Services Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Pharmaceutical CDMO Services Sales Market Share by Country/Region (2024)
Figure 8. Pharmaceutical CDMO Services Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Pharmaceutical CDMO Services Market Size Market Share by Type in 2024
Figure 10. Pharmaceutical CDMO Services in Innovative Medicine
Figure 11. Global Pharmaceutical CDMO Services Market: Innovative Medicine (2020-2025) & ($ millions)
Figure 12. Pharmaceutical CDMO Services in Patented Drug
Figure 13. Global Pharmaceutical CDMO Services Market: Patented Drug (2020-2025) & ($ millions)
Figure 14. Pharmaceutical CDMO Services in Patent Expired Drug
Figure 15. Global Pharmaceutical CDMO Services Market: Patent Expired Drug (2020-2025) & ($ millions)
Figure 16. Global Pharmaceutical CDMO Services Market Size Market Share by Application in 2024
Figure 17. Global Pharmaceutical CDMO Services Revenue Market Share by Player in 2024
Figure 18. Global Pharmaceutical CDMO Services Market Size Market Share by Region (2020-2025)
Figure 19. Americas Pharmaceutical CDMO Services Market Size 2020-2025 ($ millions)
Figure 20. APAC Pharmaceutical CDMO Services Market Size 2020-2025 ($ millions)
Figure 21. Europe Pharmaceutical CDMO Services Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Pharmaceutical CDMO Services Market Size 2020-2025 ($ millions)
Figure 23. Americas Pharmaceutical CDMO Services Value Market Share by Country in 2024
Figure 24. United States Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Pharmaceutical CDMO Services Market Size Market Share by Region in 2024
Figure 29. APAC Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
Figure 30. APAC Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
Figure 31. China Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 35. India Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Pharmaceutical CDMO Services Market Size Market Share by Country in 2024
Figure 38. Europe Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
Figure 39. Europe Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
Figure 40. Germany Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 41. France Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 54. APAC Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 55. Europe Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 57. United States Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 58. Canada Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 59. Mexico Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 60. Brazil Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 61. China Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 62. Japan Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 63. Korea Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 65. India Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 66. Australia Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 67. Germany Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 68. France Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 69. UK Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 70. Italy Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 71. Russia Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 72. Egypt Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 73. South Africa Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 74. Israel Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 75. Turkey Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 76. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 1. Pharmaceutical CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CDMO Services Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Pharmaceutical CDMO Services Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Pharmaceutical CDMO Services Sales Market Share by Country/Region (2024)
Figure 8. Pharmaceutical CDMO Services Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Pharmaceutical CDMO Services Market Size Market Share by Type in 2024
Figure 10. Pharmaceutical CDMO Services in Innovative Medicine
Figure 11. Global Pharmaceutical CDMO Services Market: Innovative Medicine (2020-2025) & ($ millions)
Figure 12. Pharmaceutical CDMO Services in Patented Drug
Figure 13. Global Pharmaceutical CDMO Services Market: Patented Drug (2020-2025) & ($ millions)
Figure 14. Pharmaceutical CDMO Services in Patent Expired Drug
Figure 15. Global Pharmaceutical CDMO Services Market: Patent Expired Drug (2020-2025) & ($ millions)
Figure 16. Global Pharmaceutical CDMO Services Market Size Market Share by Application in 2024
Figure 17. Global Pharmaceutical CDMO Services Revenue Market Share by Player in 2024
Figure 18. Global Pharmaceutical CDMO Services Market Size Market Share by Region (2020-2025)
Figure 19. Americas Pharmaceutical CDMO Services Market Size 2020-2025 ($ millions)
Figure 20. APAC Pharmaceutical CDMO Services Market Size 2020-2025 ($ millions)
Figure 21. Europe Pharmaceutical CDMO Services Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Pharmaceutical CDMO Services Market Size 2020-2025 ($ millions)
Figure 23. Americas Pharmaceutical CDMO Services Value Market Share by Country in 2024
Figure 24. United States Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Pharmaceutical CDMO Services Market Size Market Share by Region in 2024
Figure 29. APAC Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
Figure 30. APAC Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
Figure 31. China Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 35. India Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Pharmaceutical CDMO Services Market Size Market Share by Country in 2024
Figure 38. Europe Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
Figure 39. Europe Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
Figure 40. Germany Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 41. France Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Pharmaceutical CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 54. APAC Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 55. Europe Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 57. United States Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 58. Canada Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 59. Mexico Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 60. Brazil Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 61. China Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 62. Japan Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 63. Korea Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 65. India Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 66. Australia Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 67. Germany Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 68. France Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 69. UK Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 70. Italy Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 71. Russia Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 72. Egypt Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 73. South Africa Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 74. Israel Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 75. Turkey Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
Figure 76. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Pharmaceutical CDMO Services Market Size 2026-2031 ($ millions)
More Publications
Global Anti-Neoplastic Pharmaceutical Agents Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
96 pages
